Eosinophil granulocytes are activated during the remission phase of ulcerative colitis

M Lampinen1, A Rönnblom, K Amin

  • 1Department of Medical Sciences, Gastroenterology Group, Clinical Chemistry and Medicine, University Hospital, S-751 85 Uppsala, Sweden. maria.lampinen@medsci.uu.se

Gut
|May 12, 2005
PubMed

Insights

Activated eosinophils are found in both active and inactive ulcerative colitis (UC), suggesting a role in inflammation and potentially epithelial repair. Neutrophils are active during active UC but not in remission.

Area of Science:

  • Gastroenterology
  • Immunology
  • Cell Biology

Background:

  • Ulcerative colitis (UC) involves chronic inflammation of the gastrointestinal tract.
  • The roles of eosinophils and neutrophils in UC pathogenesis are not fully elucidated.
  • Understanding immune cell activity in UC is crucial for developing targeted therapies.

Purpose of the Study:

  • To develop a flow cytometry method for analyzing intestinal eosinophils and neutrophils.
  • To compare the distribution and activation of these cells in different stages and locations of UC.
  • To investigate the cellular mechanisms underlying UC and its remission.

Main Methods:

  • Biopsy samples were collected from multiple colonic locations and the terminal ileum in UC patients and controls.
  • Cell suspensions were prepared and incubated with fluorescently labeled monoclonal antibodies.
  • Flow cytometry with scatter plot-gating and specific antibodies was employed to quantify and assess cell activity.

Main Results:

  • Eosinophils were more numerous and active in active UC compared to controls, with even higher activation during inactive UC.
  • Neutrophils increased in number and activity during active UC but not inactive UC.
  • Activated eosinophils were prominent in the rectum in distal colitis, while activated neutrophils were localized to the sigmoid colon and rectum.

Conclusions:

  • The developed flow cytometry method effectively characterizes intestinal granulocytes in UC.
  • Neutrophils are key players in active UC inflammation, exhibiting a resting state during remission.
  • Activated eosinophils in UC suggest both pro-inflammatory and potential epithelial repair roles, particularly during inactive disease.
Abstract

Related Concept Videos

Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
721
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
703
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
1.5K
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal...
57
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
69
Inflammatory Bowel Disease IV: Clinical Manifestations01:20

Inflammatory Bowel Disease IV: Clinical Manifestations

Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The...
64